Thursday, May 21, 2026

My Video on Molecular Biology

As I wrote earlier, I've run out of gas with respect to posting new insights on Alzheimer's research. But I'm still busy (and still OK). One thing I did was to post a YouTube video intended to update Baby Boomers on what's happened in the world of biology since we were in the 10th grade. It's relevant to an understanding of recent revelations in Alzheimer's research. You can see it by clicking here. 

It does dig fairly deeply into molecular biology, and it's likely to go too deep for many of you. Also, I have some questions about how all of this makes sense, and I may disappoint some of you in where I go with it. Here is the index:

Chapters 00:00 - 02:22 - Introduction 02:23 - 06:20 - On the philosophy of science 06:21 - 08:52 - Religion vs. science 08:53 - 10:40 - Biology - Then and now 10:41 - 14:15 - Organelles and the cell membrane 14:16 - 18:13 - DNA - What is it, what does it do? 18:14 - 19:07 - Prokaryotes and eukaryotes 19:08 - 23:12 - DNA replication 23:13 - 26:32 - Mitosis 26:33 - 27:57 - Meiosis 27:58 - 29:25 - Charles Darwin on how evolution proceeds 29:26 - 34:23 - The Central Dogma and protein synthesis 34:24 - 41:38 - Energy processing in the cell 41:39 - 44:50 - Cellular respiration 44:51 - 45:17 - Utilization of energy within the cell 45:18 - 47:33 - The origin of life and the Cambrian Explosion 47:34 - 49:48 - Do the numbers add up? 49:49 - 50:23 - Gene regulatory networks 50:24 - 52:34 - Darwin's very dangerous idea 52:35 - 53:13 - The chicken ... or the egg? 53:14 - 54:14 - Evolution and sickle cell anemia 54:15 - 55:05 - Evolution and the Peppered Moth 55:06 - 58:36 - Hypotheses on how organisms might increase in complexity 58:37 - 01:00:20 - The universal acid 01:00:21 - 01:01:47 - Back to the Cambrian Explosion 01:01:48 - 01:02:08 - The work of an engineer? 01:02:09 - The bacterial flagellal motor

Thursday, March 5, 2026

I'm Still Here

As I posted back in November, continually generating content for the blog has gotten to be too much of a burden.  While I am committed to updating you on any changes in my life (or, perhaps, lack of changes) relative to my story in Beating the Dementia Monster, I don't plan on commenting anymore about Alzheimer's news.  But I am hearing from folks wondering why I've been so quiet -- it's because nothing is really happening.

I am in a whole slew of research studies, and I get some feedback from them.  I recently had one MRI and one amyloid PET scan.  I'm supposed to have a tau PET scan sometime, but they haven't scheduled it yet.  It's been several months since the PET scan, and a month or two since the MRI.  They are in no rush to give me any feedback, so I don't expect to hear from them for some time yet.  But, based on my results from 2022 and how well I feel, I don't expect any surprises.  But I'll post when I do hear back.

When I told my neurologist in Seattle that I didn't see the point in coming back to her, she asked me to continue, but relax to coming once in three years.  So this fall will make 3 years.  That will include the full suite of psychometric testing.  I'll share the outcome of that.

Along with the MRI, I did have a scaled back -- but still intense -- set of psychometric tests.  Because it's for research, they don't tell me the results.  But I've taken enough of these to be able to tell when I've done well.  And I'm sure I did fine.

So Amy and I make it to the gym most days. We attend to our diets and stay socially active.  My biggest problem is sleep, and I'm lucky to get 5 and a half hours.  But my Fitbit tells me that I'm usually getting at least an hour of deep sleep.  As we said in Beating the Dementia Monster, deep sleep is most critical for Alzheimer's prevention and treatment.

If anything exciting happens, I'll post here.

Friday, November 21, 2025

What's Going on with Me

It's been a month since I last posted.  Is something going wrong with me?  No, I'm fine.  I guess that, after more than seven years and more than 550 posts, posting has become something of a chore.  My heart isn't in it as it was before.

Now, I'm not closing down the blog.  I believe I committed in Beating the Dementia Monster to at least keeping people updated on my case.  Does continuing my lifestyle changes have durability with respect to maintaining my memory and cognition?  Will (as some propose) my lifestyle changes use up all of the available stem cells in my hippocampus and revert me to an evolving dementia?  I want to know the answers as much as any of you!  So when I encounter new milestones, I'll share those.

At the moment, my sense is that my memory and cognition is consistent with healthy men my age.  This doesn't mean that things don't happen that cause me concern, but overall I think I'm fine.  My care team has not evaluated me for two years, and they say they won't test me again until a year from now.  I plan to share that outcome because it will say a lot about the durability of my strategy. 

In the meantime, I am participating in a number of research studies that test me, and I expect to get some kind of insights from them.  Yesterday, I had an amyloid PET scan that will say something about where my brain is at.  They tell me I can have the results in about 90 days.  Before then, I should also have a tau PET scan and another MRI.  Even though these are for research, the radiologist's reports are entered into my medical record, and I have access to them.  I also expect more psychometric testing for these studies.  So I'll share what I learn.

Will I occasionally come across some news important enough to prompt me to discuss it here?  Maybe.  But, always watching for news and then translating into something my Mom can understand (even though she's pretty smart) has been an increasing source of stress.  So I feel a lot better after giving up on tracking research.

 

Saturday, October 11, 2025

More News from the World of Research

I continue to keep an eye out for interesting developments in the world of Alzheimer’s research.  A few have recently popped up for me. So here are some of them: 

1. SHIELD – A new acronym. You may be familiar with the mnemonic for recognizing stroke: FAST – face, arm, speech, time. So now there’s a new one for Alzheimer’s: SHIELD – sleep, head injury prevention, exercise, learning, and diet. Paying attention to these will reduce your risk of developing Alzheimer’s and at least slow it down if you do develop it. This mnemonic was developed by neuroscientist Rudolph Tanzi, co-director of the McCance Center for Brain Health at Harvard-affiliated Massachusetts General Hospital. You can read more here. 

2. Your brain needs sleep. And speaking of sleep, we’ve had a lot to say about it and its relationship to Alzheimer’s disease. Now, there’s new evidence regarding how sleep works to protect the brain. It’s known that human growth hormone, or somatotropin, is released in the body while we sleep. It stimulates growth, cell reproduction, and cell regeneration, notably in the brain. Researchers at the University of California, Berkeley concluded that sleep and growth hormone form a tightly balanced system with feedback loops. Neuroscientist Daniel Silverman is quoted as saying, "Sleep drives growth hormone release, and growth hormone feeds back to regulate wakefulness, and this balance is essential for growth, repair, and metabolic health." You can read more here. 

3. More on sleep and your brain. And still speaking of sleep, a study at the Mayo clinic found that chronic insomnia may be just as influential on the development of dementia as being a carrier of the APOE4 gene. This was found by following 2,750 people over the age of 70 for five and a half years. The study participants took annual cognitive tests and had brain scans. Researchers tracked the development of amyloid plaques and “white-matter hyperintensities.” The white-matter hyperintensities were damage to parts of the brain involved in communication within the brain. One thought is that these two factors might magnify each other. Here’s a link to the published research. You can read a more easily understood article here. 

4. Cocoa and multivitamin supplements may – or may not – delay cognitive decline. New research provides evidence that cocoa and multivitamin supplement consumption may reduce the progression of cognitive decline and help protect against cardiovascular disease. For brain health, the results were more compelling for multivitamins than the cocoa supplements. Called the COcoa Supplement and Multivitamin Outcomes Study (COSMOS), it was conducted at Brigham and Women’s Hospital – an affiliate of Harvard Medical School in Boston – and the Fred Hutchinson Cancer Research Center in Seattle (where my wife was treated for cancer a number of years ago). Wake Forest University also participated. The study involved 12,666 women aged 65 or older and 8,776 men aged 60 or older. They were followed for an average of 3.6 years through the end of 2020. At least with regard to the multivitamins, daily multivitamin slowed cognitive aging by approximately 60%, or the equivalent of 1.8 years over the 3 years of the study.  It was harder to find a positive effect from the cocoa for brain health.  However, the study suggested a 27% reduction in cardiovascular death and greater cardiovascular benefits among those taking the cocoa supplements regularly. Here’s a link to the research. Here’s a link to an article on the study. 

5. Are all ultra-processed foods (UPFs) bad? Perhaps not. While ultra-processed foods (e.g., frozen dinners, chips, soft drinks, and packaged snacks) are clearly inferior nutritionally to fresh fruits and vegetables, applying the same negative label to them all may be a mistake. According to some researchers from the UK, the label UPF is a blunt instrument that excludes some foods that may actually be good for you.  Since UPFS taste good and encourage eating (or overeating), they may be beneficial to older people who tend to lose weight, sometimes dangerously. And whole grain breakfast cereals would qualify as UPFs while being quite nutritious. Here’s an article on this. Here’s a link to the research. (This is all well and good, but I’m sticking with the MIND diet.)

Sunday, October 5, 2025

M116 RIP, 1907-2024

Maria Branyas Morera, known to the world of science as Subject M116, died on August 19, 2024 at the age of 117.  Not surprisingly, she has been the subject of considerable interest and investigation.  Of course, everyone wants to live to 117 (don't they?), and so we want to know what her secret was.  The most notable evaluation of her story was published in the journal Cell Reports Medicine,  What were the takeaways?  Well, two were that she stayed away from toxic people, and she ate a lot of yogurt.  Apparently, a lot of yogurt.  (Yogurt is, of course, good for the gut microbiome.  And what's good for the gut is good for the brain.)  The researchers said that they "performed a high-throughput multiomics study of the world’s oldest living person, interrogating her genome, transcriptome, metabolome, proteome, microbiome, and epigenome, comparing the results with larger matched cohorts."  (Take that, you skeptics.) 

Maria was actually born in the United States to Spanish parents, but her family returned to Spain when she was 8, where she grew up and lived out her life.  Today, we think of Spain as a peaceful place, but it would have been racked by civil war, two world wars, the Spanish Flu, and then a terribly repressive government during the first half of her life.  (Remember for whom the bell tolls ... it tolls for thee.  (Apologies to Ernest Hemingway and John Donne.))

Not surprisingly, the findings of the Cell Reports study focused on both genetics and lifestyle.  She allowed doctors to collect samples of her blood, saliva, urine, and stool and these were studied.  These provided insights on aspects of her health, notably the health of her gut microbiome.  

The researchers observed that she had genetics that favored a long life.  Her lifestyle was what you would expect -- she was socially active (but not with toxic people), she didn't smoke, she didn't drink, and she got regular exercise.  (Although I'm not sure how many jumping jacks she was doing at 116.)  Regarding her diet, the researchers pointed out that she ate a lot of yogurt.  They thought that the yogurt reduced inflammation, which helped extend her life.  

In Catalonia, where her family originated and where she lived, the life expectancy for women is 86 years.  So she sure beat that.

One thing that surprised researchers was the very short length of her telomeres.  Telomeres are regions on the ends of chromosomes that shorten as you age.  They protect the chromosomes, but they shorten as you age and may be associated with lifespan.  Some research has gone into the hope that by preventing the telomeres from shortening, the folks that want to live to 117 and beyond can extend their lives.  This finding suggests that is a false hope.

I'm not sure what all of this means for the folks that want to live to 117.  In 2016, I was told I could expect to live to 85, although the way I feel today, I might go beyond that.  That's good enough for me.

Tuesday, September 30, 2025

A New Relationship Between Diet and Your Genetics

So we know that carrying one or two copies of the APOE4 gene variant is a genetic marker for increased risk of Alzheimer's disease.  We also know that consuming the Mediterranean diet (MedDiet) reduces your risk of developing the disease.  (I have been focusing on the MIND diet, which is a modified MedDiet.)  But is there an interplay between these two factors?  Maybe so.

According to a recently published study in Nature Medicine, it appears that the MedDiet is much more helpful for people carrying one or two copies of the APOE4 gene.  Recall that APOE4 is the variant of the APOE gene most associated with the development of Alzheimer's.  While some carriers never develop the disease, and some non-carriers do, it still elevates your risk.  There are at least 30 different genes that can contribute to your risk, but the APOE4 is the strongest marker.

But what did the researchers do, and what did they find?  Researchers at Brigham and Women’s Hospital, Boston, studied the serum metabolites in thousands of subjects and compared these to their genetic markers and to their disease status.  

But what's a serum metabolite?  These are the chemical compounds found in blood that are the result of the metabolism of various nutrients.  Obviously, the metabolites from a serving of kale will be different than those from a Snickers bar.  And so, they were able not only to determine who was actually following the MedDiet faithfully, but also to see who's disease status was most affected by their diet -- people with the APOE4 gene or those with the other two variants.  And for that matter, carriers of one or two copies.

As it turns out, persons with kale metabolites in their blood experience a greater benefit of resistance to Alzheimer's if they carry the APOE4 gene than if they didn't.  This also goes for the metabolites of other foods in the MedDiet.  Leafy greens containing some antioxidant carotenoids just stand out.  Note that carriers of the other variants still benefit from the MedDiet, but this population benefits the most.

So, a word to the wise.  If 23&Me tells you that you carry one or two copies of the APOE4 gene -- eat your greens!  (And if you don't ... well, eat them anyway.)

Here's an article of the study.  

Sunday, September 21, 2025

Today Is World Alzheimer's Day

Today is World Alzheimer's Day.  The Alzheimer's Association describes it: "World Alzheimer's Day, which takes place every Sept. 21, is a global effort to raise awareness and challenge the stigma around Alzheimer's disease and other dementia.  Join the Alzheimer's Association as we recognize the more than 55 million people across the world who are affected by this terrible disease. Whether you fundraise for the cause, share information about Alzheimer's, or talk to a loved one about dementia, you can make a difference."

Wednesday, September 10, 2025

More Stories in the News

Back on August 25, we posted about stories in the news regarding Alzheimer’s and brain science that had caught my attention. Since then, a few more stories have popped up. Several involved early detection of AD. Here’s what I’ve seen: 

1. While “neural plasticity,” the ability of the brain to constantly break and reconnect pathways in the brain, is an important feature of how a healthy brain functions, this process may go to excess in persons developing Alzheimer’s. Higher flexibility in the networks involved with vision may turn out to be a new biomarker for diagnosing the disease. Here’s an article about it. 

2. Another one bites the dust: A phase 1 study of another anti-amyloid beta antibody developed by a company named Prothena found an unacceptably high rate of brain swelling. The treatment candidate was named PRX012. Brain swelling is a significant side effect for all of the monoclonal antibody treatments, like Aduhelm and Leqembi. Here’s an article about PRX012. 

3. If you successfully completed 10th grade biology, you know that adenosine triphosphate, or ATP, facilitates the transfer of energy in the cell. (Of course you do.) In so doing, the ATP molecule loses a phosphate group that must be restored. It’s the job of another molecule called creatinine to take care of that. For some time, creatinine supplements have been sold to help facilitate physical exercise by supporting the transfer of energy in muscles. But, if you read Beating the Dementia Monster and this blog, you know that the brain uses a LOT of energy itself, and creatinine plays a role there too. New research found that creatinine supplementation in older adults (like me) appears to support healthy brain functioning. So my wife and I take 5-gram creatinine gummies once a day. Here’s an article about it. 

4. A recent study found that the lower concentrations of omega-3 fatty acids in women may help explain why women are more likely to develop Alzheimer’s. This might be remedied by women consuming more foods and supplements with omega-3s. (For example, by eating more salmon.) While we know that beta amyloid plaques and tau tangles characteristically appear in the brains of people with Alzheimer’s, Alois Alzheimer also identified the presence of lipid (fat) droplets in the brain. Failure to move the fats out of the cells may be a part of AD pathology, and it may be we haven’t been paying enough attention to this. And it may be that a poor balance between LDL and HDL cholesterol is inhibiting the proper metabolism of these fats, causing them to accumulate. (Cholesterol has an important role in fat metabolism.) This appears to be more the case with women, and some believe it might explain why women are more likely to develop Alzheimer’s. Part of the equation is the omega-3 fatty acids found in, for example, some fish oils. The recommendation would be to ensure you are consuming enough omega-3 fatty acids, especially if you are a woman. Here’s an article about it. 

5. Is Alzheimer's an autoimmune disease?  We knew that changes in sense of smell can suggest the onset of Alzheimer’s. But why? In Beating the Dementia Monster, we discussed the microglia, cells that form part of the unique immune system in the brain and how they may play a role in Alzheimer’s. Recent research suggests that a loss of control of the immune process causes the microglia to incorrectly identify olfactory nerves and attack them. This would occur in the context of the development of the disease. Hence to correlation between loss of smell and the appearance of the disease. Here’s an article about it. 

6. As we’ve discussed before, there is ample evidence associating vitamin D supplementation with brain health. It’s not just about strong bones. But why? Some recent research correlates adequate vitamin D with the preservation of telomeres, the caps on the ends of chromosomes. They get shorter with age, which makes us more vulnerable to the diseases of old age – like cancer and Alzheimer’s. Vitamin D consumption, whether in the MIND diet or with supplements, protects the telomeres that protect us. Here’s an article about it. 

7. New research reinforces our understanding of the role that problems in the gut might play in influencing the development of Alzheimer’s. The answer is, of course, a high-fiber diet – which is the answer to a lot of problems in the gut. Apparently, immune cells in an unhealthy gut can travel to the periphery of the brain and contribute to the development of the disease. At least in mice. While this finding reinforces our existing observation that a high-fiber diet is essential to brain health, it opens to door to more possibilities in how to understand and treat the disease. Here’s an article about it. 

8. There’s a new three-minute brain wave test that, so far, appears to be very good at diagnosing Alzheimer’s. It’s called the Fastball EEG. Apparently, it’s more reliable than the hours of testing I was subject to when I was diagnosed. Basically, the subject learns a set of eight pictures. Then, he or she is shown a blast of pictures at a rate of three per second. One in five of these is one of the eight pictures the subject learned previously. The EEG then registers the reaction the brain has to what it sees. This is pretty interesting, but, for ease of administration, it’ll come in second to the new blood tests we’ve discussed previously, and it may be no more accurate. Here’s an article about it.  My sense is that this test might be good at recognizing hippocampus damage caused by Alzheimer's, but it doesn't probe the other parts of the brain which may be failing due to other diseases and disorders.

This isn't all.  More next time.

Saturday, August 30, 2025

Now We Are Seventy-Six (Apologies to Winnie the Poo.)

Readers of this blog and of Beating the Dementia Monster know that, when I was 66, I was told by an authoritative neuropsychologist and Alzheimer’s researcher that I was on track to be dead by the time I was 75. My subsequent study of the disease found his statement was justified. However, I had also told him that I’d recently done a complete flip of my lifestyle, shifting from one that was quite sedentary to one that was active – joining the gym and paying particular attention to my diet. While I had been working from home without social interaction, I had retired and was now working with other men at the local food bank. This provided more social interaction than I’d had when I was employed. He indicated that, if I kept all of that up, I could expect to live at least to 85. In other words, based on his extensive experience with the disease, I was buying at least 10 years. 

So, about a year ago, I announced here that I had reached that 75, and I wasn’t dead. At least not yet. After all, there are 365 days in a year, and, well, who knows what’ll happen during all those days. I am, however, happy to report that I made it all the way through those 365 days, and I am still not dead. 

But what transpired during those 10 years? Readers will recall that I was in free-fall back in 2015. I had to stop driving and had episodes when I couldn’t recall our zip code or phone numbers of 35 years, even when prompted. After hours of testing at the University of Washington’s Brain Wellness Center I was pronounced “impaired.” In 2017 and 2018, my brain MRIs were for someone in memory care. 

Nevertheless, after about six months of fairly aggressive exercise and work on my diet, I began to see improvement. I may have initially been a bit premature, but I did go back to driving, and I drive quite safely now. Even in Seattle traffic. (But fortunately, we don’t go there very often.) 

I am still followed by the neurologists in Seattle, and I continue to do quite well. My personal assessment is that I continued to improve until 2019, when I seemed hit a plateau. A couple of years ago, I had an essentially normal MRI result, and my memory and cognition are no worse than anyone else I know my age. Within the last hour of preparing this post, I took an online cognitive test for a study at the University of California, San Francisco, and I’m sure that I did just fine. Not perfect, but just fine. About six months ago I took another cognitive test administered for a study at the Brain Wellness Center in Seattle. They weren’t allowed to tell me my exact results, but the results were assessed by the same neuropsychologist who spoke with me back when I was 66. He was at least allowed to tell me that I did just fine. So life is good. 

After we published Beating the Dementia Monster, I met a number of people struggling with memory loss. I usually met them through a spouse who was concerned about them. As I met more and more people who were struggling, I began to appreciate how hard it is for many people to flip their lifestyle the way I did. While I’d lived a very sedentary lifestyle for many years, I wasn’t dealing with any other chronic diseases (yet), and I’d already put considerable effort into getting my weight under control. So I had a head start on getting my physical self in order. I have, however, come to appreciate how hard it can be for many others to replicate my experience, especially if they suffer from chronic diseases. And so, while I do try to encourage people in their 60s and 70s to live well, I’m just as eager to encourage younger people to pay attention to their diet and exercise. 

I do hear from some of you from time to time, and I appreciate that. I’m hoping that there are many who see in me what they can do for themselves and are able to take control of actual or potential memory loss. But it can be hard.

Monday, August 25, 2025

In the News

I haven’t posted much lately, especially with summer travel to the East Coast and North Cascades mountains.  But I have been watching the news on Alzheimer’s disease research.  Here are some things that caught my eye:

1. A study found that having a purpose in life was linked to lower dementia risk.  The study of “over 13,000 adults found that having a strong sense of purpose in life is linked to a reduced risk of dementia. People with a greater purpose were 28% less likely to develop cognitive impairment, even when accounting for genetic risk and other factors.  This was consistent across racial and ethnic groups and modestly delayed the onset of decline by more than a month over eight years. The findings suggest that building purpose through relationships, goals, or meaningful activities may help keep the brain resilient with age.”  Click here.

2. A study found that two supplements can affect levels of gamma-glutamyl transferase (usually referred to as GTP), which is a protein where low levels are seen in Alzheimer’s disease.  (I didn’t know this.)  Some study findings which were published in the journal GeroScience, described how two compounds, nicotinamide (a form of vitamin B3) and epigallocatechin gallate (an antioxidant found in green tea), helped restore guanosine triphosphate, a key molecule that fuels energy production in brain cells. In laboratory experiments on neurons, this treatment not only reversed age-related cellular decline but also enhanced the cells’ ability to clear away amyloid protein clusters, a defining feature of Alzheimer’s.  But these findings seem to have a long way to go before we get to a protocol.  I already take nicotinamide myself, although I don’t drink green tea as often as I should.  Click here.  And here.

3.  We already knew this, but Wendy Suzuki continues to bring attention to the importance of aerobic exercise for brain health.  Click here.

4.  Researchers at St. Jude’s found that a protein, called midkine, blocks amyloid beta from forming harmful clumps linked to Alzheimer’s.  If this checks out, it could lead to breakthrough treatments.  Click here.

5.  Researchers at Harvard found a connection between lithium deficiency in the brain and Alzheimer’s disease.  “The team discovered that loss of lithium in the human brain is among the earliest alterations linked to Alzheimer’s, while in mice, reduced lithium sped up both brain damage and memory decline.”  Click here.

6.  Deficiencies in omega-3 fatty acids may promote Alzheimer’s in women but not in men.  Is this why women are more likely to develop Alzheimer’s than men?  Click here.

7.  Researchers at Rush University (home of the MIND diet) believe they have found out why the MIND diet is effective.  Click here.

8.  In Beating the Dementia Monster, we said that there was a sweet spot for exercise to improve brain health.  But too much is detrimental.  Here’s new research on how it is that too much can be detrimental.  Click here.  Of course, we’re talking a lot of exercise to get over the peak for benefit to get to a downside.

9.  Can AI develop an even better diet for dementia prevention?  The Chinese say they have it.  Click here.  (China is second only to the US government in Alzheimer's research.) 

Thursday, August 14, 2025

Now We Have It -- Results of the US Pointer Study

Back in 2020, in Beating the Dementia Monster, we expressed hope that the US POINTER study by the Alzheimer's Association, then in progress, would confirm the results of an important earlier study, the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER).  The FINGER study was to be the "first study to apply a multidomain approach to dementia prevention. The main aim was to prevent cognitive impairment, and secondary aims include decreasing disability, cardiovascular risk factors and related morbidities, depressive symptoms, and to have beneficial effects on the quality of life."  We first discussed the FINGER study in 2018 and have revisited it several times since.  You will also recall that the multidomain approach to battling Alzheimer's disease was an important theme of Beating the Dementia Monster.

The FINGER study applied the multiple domains of: 1) Dietary guidance, 2) Physical activity, 3) Cognitive training and social activities, and 4) Intensive monitoring and management of metabolic and vascular risk factors.

While the FINGER study provided valuable information on the power of lifestyle to offset cognitive decline in the elderly, it had its critics.  The strongest criticism was that the subjects were uniformly white northern Europeans.  We know that dementias manifest differently in diverse populations.  And it's a principle of the scientific method that others should duplicate the results of your findings.  Therefore, several countries around the world set out to confirm the findings, although not necessarily by exactly duplicating the study.  In the United States, it was the US POINTER study.

But then there was Covid.  As with the MIND diet study, the lockdowns seriously disrupted and delayed progress on completing the study and analyzing the results.  So we had hoped to see results by 2022, but we're only seeing them now.

It's important to note that both the FINGER study and the US POINTER studies were randomized controlled trials.  Unlike longitudinal studies, they actually changed peoples' lifestyles and then measured the results.  Results were compared to a control group whose lifestyle was not directly changed.  This is far superior to the much more common longitudinal studies, in which populations are studied for correlations between, say, lifestyle and incidence of dementia.  In longitudinal studies you find correlations, but correlation is not causation.  And confounding factors can fly under the radar and bias your results.  Randomized controlled trials are much harder and more expensive to conduct, but they yield much more reliable results.

Topline results of the US POINTER study were announced at the recent Alzheimer's Association International Conference in Toronto.  The results were very positive, however I was a bit disappointed.  At least so far.  

Here's what they said: "... a structured lifestyle intervention of regular moderate- to high-intensity physical exercise, adherence to the MIND diet, cognitive challenge and social engagement, and cardiovascular health monitoring led to a statistically significant greater improvement in global cognition over 2 years relative to a lower-intensity self-guided intervention."  To which has been added, "Cognitive benefits were consistent across age, sex, ethnicity, heart health status, and APOE4 genotype."

Note the use of the word "improvement."  They didn't find that decline was slowed or even stopped, memory and cognition actually improved. 

Note that, rather than with a traditional control group, they compared test participants on a structured program to participants on a lower intensity, self-guided program.  For the test participants, they aggressively supervised them in changes to their lifestyles, while, for the "control group," they simply advised people on how to live well.  (They thought it would be unethical to discourage anyone from adopting a healthy lifestyle just to help their study.) 

For you nerds, here are the published results, or at least what's available if you don't purchase the whole thing.  There's a little more here.  And more here.

So this is a ringing endorsement of the multidomain approach to brain health.  But these were the "topline" results.  Some things remain to be discerned.  Note that they never mentioned Alzheimer's disease.  I think we can think of "topline" as "preliminary."  They haven't finished evaluating the results, and they haven't gotten to the point of saying anything about Alzheimer's.  They still need to publish information about how many test participants in the structured group developed Alzheimer's (during the two-year period) compared to how many did in the unstructured ("control") group.  That's what I was looking for back in 2020, and I'm still waiting.

Monday, August 11, 2025

Eating Pizza and Dynamic Cerebral Autoregulation. Huh?

We know that the MIND diet encourages us to consume a polyunsaturated fat called "olive oil," but warns us against saturated fats.  Like the cheese in that pizza.  That's not fair.  So why do they tell us that?

Well according to some new research, even one meal high in saturated fat impairs blood flow to the brain.  And we associate brain blood flow problems with the development of Alzheimer's disease.  

"Dynamic cerebral autoregulation (DCA)" is a process likened to a shock absorber in the brain with respect to blood pressure and blood flow.  Blood vessels must remain flexible to accommodate sudden changes in blood pressure such as occur during exercise.  Or even just getting up out of a chair.  DCA ensures blood flow to the brain remains stable despite routine changes in blood pressure, but it depends on flexible blood vessels.  

Levels of fat in the blood rise and peak after around four hours after eating a meal high in saturated fat.  This is thought to cause blood vessels to become stiffer and lose some of their flexibility.  If so, this could disrupt DCA, restricting blood flow around the body, including to the brain.  This concept is not new, but how well is the brain protected when this occurs?  According to some new research, maybe not very well.

The researchers employed about 20 young men and about 20 older men for the study.  They fed them a big milk shake with about the same calorie count and fat content as a fast food meal -- 1,362 calories and 130g of fat.  Using ultrasound, they then measured the effects of the meal on their vascular system over a four-hour period while they exercised periodically. 

What did they find?   The high-fat meal impaired the ability of the blood vessels associated with heart health to open.  This was true in both young and old participants, although it was about 10% worse in the older cohort.  So the impairments reduced the body's ability to buffer changes in blood pressure.  This can easily suggest to us that consuming saturated fat -- even once -- can affect the vascular system in a way that promotes the development of Alzheimer's disease.  Sad news, I'm afraid.

But it gets worse.  The authors published earlier research in which they found saturated fats caused an increase in unstable, cell-damaging molecules, called free radicals, and caused a decrease in the nitric oxide molecules that help blood vessels relax and open.  The relaxed blood vessels are supposed to allow blood to transport oxygen and glucose around the body -- including to the brain.  Less nitric oxide means less flexible blood vessels, which means poorer blood flow to the brain.  This appears to be the link to problems with DCA.  (BTW, the discovery of the effect of nitric oxide on the vascular system was good for a Nobel Prize in 1998.)

Here's an article about the research.  Here's a link to the actual research.

Tuesday, July 29, 2025

Already approved cancer drugs reverse Alzheimer's? Maybe...

It's not unusual for a drug previously approved for treatment of one condition to be found to also treat something different.  Like many men my age, I take tamsulosin for my prostate, which was originally developed as a treatment for high blood pressure.  Tamsulosin is one of the α1‐blockers, most of which reduce blood pressure.  But that didn't work out in this case.  It was later found to treat benign prostatic hyperplasia (BHP), which makes older men get up a lot during the night.  So, in 1997, it was approved for BHP and not for hypertension.

So what about Alzheimer's?  Are there drugs already approved for some condition that would coincidentally treat Alzheimer's disease?  And treat it effectively?  Suppose we sifted through some massive data base of case histories and look for people who received this or that treatment and then showed improvement in Alzheimer's symptoms?

Well, someone did that, and the results were remarkable.  According to this research, published in the journal Cell, there are two drugs approved for the treatment of cancer that can reverse Alzheimer's symptoms.  The drugs were letrozole and irinotecan.  (Letrozole, like all drugs, has significant side effects, but it looks like irinotecan can be downright nasty.)

The drugs were first identified by analyzing an array of drugs for a "signature" on how they affected the generation of proteins in the brain.  The researchers then looked for correlations with Alzheimer's improvements in a database of case histories.  They then set about testing the drugs on mice.  (Yep, mice again.)  And, well, it checked out.  At least with the mice.

With the mice, the two drugs reversed multiple aspects of Alzheimer’s disease.  They undid the protein signatures in brain cells that are seen as the disease progresses.  They reduced both the formation of amyloid plaques and tau tangles seen with brain degeneration. And -- the most important thing -- they restored memory. 

So that's mice.  But where do we go from here?  Here's an article about the study.  They are, of course, quite excited about results with mice, but there's nothing about carrying this forward with people.  I sure hope something is going on with this.

Wednesday, July 16, 2025

Women are more prone to Alzheimer's. Why?

It's well understood that women are more prone to develop Alzheimer's disease than men.  But, of course, women live longer than men.  So it stands to reason that by simply living longer, women will be more susceptible to any disease of old age.  But the numbers don't add up.  Women develop Alzheimer's in numbers too much greater than men to be simply accounted for by a longer life.  Women are also more likely to develop MS than men, but men are more likely to develop Parkinson's, brain tumors, and epilepsy.  Why is that?

I recently came across this interesting article that addresses possible explanations.  For Alzheimer's, two dynamics appear to be the differences in male and female chromosomes (XX for women and XY for men) and hormonal changes during menopause.

The X and Y chromosomes contain genes for sex differences.  However, while women have two X chromosomes, one of then is mostly silenced.  Mostly.  Those genes not silenced (on the chromosome that men lack) appear to be related to the immune system, brain function, and Alzheimer's disease.

The article discusses the consequences of hormonal changes during menopause, but sheds little light on how they might influence the development of Alzheimer's disease.  However, we did write about this back in 2018, with a link to a possibly more insightful article.  Or maybe not.  Mostly, they acknowledge that there must be a role for sex hormones in the development of Alzheimer's, but it's really not clear how that works.

Sunday, July 13, 2025

Guts and Brains ... and More Amazing News

We've written before about the gut-brain axis, that mysterious communications system between the microbes in your gut and your brain.  Somehow, they support each other, and an unhealthy gut can mean an unhealthy brain.  So we do what we can to support a healthy gut.  Which means eating right and avoiding chemicals that kill gut microbes, like artificial sweeteners and animal products that might contain antibiotics.

Neurologists like to say that "what's good for the heart is good for the brain."  We might add to that, "What's good for the gut is good for the brain." 

Therefore, we might want to consume products with probiotic bacteria, like yogurt.  However, these microbes are often destroyed in the digestive process and don't always make it out of your stomach.  So there are supplements that can help with that.  And then there are the benefits of prebiotics, "fermentable soluble food fiber," which help supply the needs of the gut microbes.  A a high fiber diet is good for the gut ... which is good for the brain.

The research on the benefits of probiotics and prebiotics continues, and there's some amazing news.  There was a recent study published in Nature Communications using twins to study the effects of consuming prebiotic supplements on memory and cognition.  The results were pretty remarkable, even over a relatively short period of time.

The supplements were inulin, a dietary fiber in the fructan class, and fructooligosaccharide (FOS), a plant carbohydrate sometimes used as a natural low calorie sweetener.  Looking at a box of Costco nut bars, I see a form of inulin listed as an ingredient.  But asparagus is a great source for both inulin and FOS.  For this study, subjects were given supplements, either with both prebiotics or with a placebo.

The study was conducted by Kings College, London, and it used 36 pairs of twins over the age of 60.  One twin was given a daily prebiotic in a protein powder and the other was given a daily placebo in a protein powder.  After only twelve weeks, there was measurable improvement in cognition.  Using some of the same tests used to diagnose Alzheimer's disease, the prebiotic test subjects showed a significant improvement in a cognitive score compared to subjects who took the placebo.

Moral of the story?  Eat your vegetables, especially the leafy greens in the MIND diet!  And it wouldn't hurt to take inulin and FOS supplements.  They're known to be cheap.

Tuesday, July 8, 2025

There Is News Worth Sharing, But...

... but I've just been really lazy.  My last post to this blog was June 5.  Now it's a month later.

But I do watch the news on Alzheimer's disease and dementia, and I accumulate topics worth sharing.  Usually, I research each story and then try to break it down in a way that would interest most people.  But now, I've accumulated a significant backlog of topics, and I have no hope of researching them all.  But I will share what's come across my computer screen and try to give a little insight on each.  So here:

1.  Alzheimer's disease could be prevented by antiviral drugs already on market.  These are NRTIs, nucleoside reverse transcriptase inhibitors, that are antivirals approved to treat HIV infection, but scientists from UVA Health at the University of Virginia found that patients taking them were less likely to develop the common form of dementia.  Click here.

2.  New Alzheimer’s drug boosts brain protection, restores memory.  A promising drug candidate, DDL-357, improves memory in Alzheimer’s mouse models by increasing levels of a protective brain protein called clusterin (CLU). CLU helps prevent the buildup of toxic amyloid-beta plaques and tau proteins, both key drivers of Alzheimer’s disease.  Click here.

3.  Do viruses trigger Alzheimer's?  A growing number of researchers think so.  (And so do we.)  Click here.

4. SSRIs restore brain function in Alzheimer’s.  A new study suggests that SSRIs, commonly prescribed antidepressants, may reduce biological markers of Alzheimer’s disease. In a cohort of 191 individuals, AD patients on SSRIs had lower levels of plasma phosphorylated tau-181, a key indicator of disease severity.  Brain scans also showed that SSRIs restored metabolic activity in an early site of tau accumulation and serotonin production. This metabolic recovery was not observed in healthy individuals, suggesting a disease-specific effect.  Click here.

5.  Facial stimulation clears brain waste and boosts aging minds.  Researchers have discovered a safe, non-invasive way to enhance the brain’s waste clearance system by mechanically stimulating lymphatic vessels just beneath the facial skin. This gentle technique significantly improves cerebrospinal fluid (CSF) drainage—a critical function that declines with age and contributes to cognitive disorders like Alzheimer’s.  The team used fluorescent tracers in mice and monkeys to uncover a new drainage pathway connecting facial lymphatics to deep lymph nodes, which remains intact even in older individuals. A handheld device that lightly strokes the skin restored youthful CSF flow in aged animals, opening up exciting potential for wearable treatments that prevent or slow neurological decline.  Click here.

6.  The cause of Alzheimer's might be coming from within your mouth.  We wrote about this in Beating the Dementia Monster, but the case continues to grow.  So floss your teeth!  Click here.

7.  Are rosemary and sage the future of Alzheimer’s treatment?  The same herb that flavors your roast chicken is showing promising results in brain research.  Click here.  And here.

8.  Ketogenic diet raises brain blood flow by 22% and BDNF by 47% in new study.  In Beating the Dementia Monster, we said that BDNF was the key biochemical factor that made the Dementia Toolkit work.  Click here. 

9.  Human brains keep making memory neurons in adulthood.  In further confirmation of what we said in Beating the Dementia Monster, a groundbreaking study shows that the human hippocampus continues producing new neurons well into late adulthood. Researchers identified neural progenitor cells—the precursors to neurons—in adults up to 78 years old, confirming ongoing neurogenesis in the memory center of the brain.  Using advanced sequencing, imaging, and machine learning techniques, they traced how these cells develop and where they reside in the hippocampus. The findings may pave the way for regenerative therapies targeting cognitive and psychiatric disorders.  (Of course, as we wrote, BDNF prompts stem cells in the hippocampus form new neurons.). Click here.

10.  Surprise discovery about sugar in the brain could help fight Alzheimer's. Stores of glucose in the brain could play a much more significant role in the pathological degeneration of neurons than scientists realized, opening the way to new treatments for conditions like Alzheimer's disease. Click here.

11.  Spermidine is great for longevity, hair growth and heart health, says expert.  We discussed spermidine briefly in Beating the Dementia Monster.  Click here. 

Thursday, June 5, 2025

Why No Cheese?

When we discuss the distinctions between the MIND diet and the Mediterranean diet, the topic of cheese, stick butter, and stick margarine comes up. They are not allowed in the MIND diet. When I speak about this, I might hear a groan from the audience. But what’s wrong with enjoying these common foods? 

The issue was identified by the late Dr. Martha Clare Morris in the longitudinal studies she and her team conducted that led to the development of the MIND diet. She saw a correlation between consumption of these foods and the development of Alzheimer’s disease. And so they were tagged as bad. So that’s correlation. But what does that tell us about causation? 

When asked about causation, dietitians usually point to the saturated fat content of these products. But I’m not sure we know that’s the case. According to some recent research, the story may have more to do with a negative effect that cheese has on the gut microbiome. In fact, while cheese may kill off some beneficial microbes, other dairy products may benefit the microbiome. Quite a paradox. 

In understanding why this might be relevant to our interest in Alzheimer’s disease, we need to recall the mystery of the gut-brain axis. There is some kind of communication between the gut microbiome and the brain, and the brain is in some ways actually controlled by the gut microbiome. The gut is sometimes called “the second brain.” How does that work? If you find out, please let me know! Nevertheless, we associate a healthy gut microbiome with a healthy brain. Eating fermented foods, like sauerkraut and kimchi, are probiotic and are associated with better brain health, because they replenish important bacteria and archaea which may have died at the hands of antibiotics and artificial sweeteners. And, perhaps, cheese. 

The research in question was published in the journal, Nutrients. It studied a relatively small cohort of older men but led to some interesting conclusions. Essentially, dairy, in general, is probiotic and increased the population of beneficial bacteria and archaea in the gut. So dairy is generally good. But cheese, on the other hand, decreased the population of beneficial microbes. Surprisingly, yogurt seemed to be neutral. Yogurt contains some microbes important to a healthy gut, but they may all get destroyed by the digestive juices in the stomach. Or so some believe. On the other hand, older men don’t eat much yogurt, so this may have been the wrong population to use for studying yogurt. (I guess I’m an exception, since I consume plenty of yogurt – mixed with blueberries, walnuts, and monkfruit sweetener.) 

So I’ll speculate. It may well be that saturated fat in butter and cheese is directly detrimental to the brain, promoting the development of Alzheimer’s disease. But also, it may be that the damage to the gut microbiome caused by cheese increased the incidence of Alzheimer’s significantly enough to influence Dr. Morris’s results. 

The research was conducted at Baylor College and involved 34 older men. They basically counted microbes in material taken from their colon mucous and correlated the counts with dairy consumption. Since the study involved such a small population of older men (who didn’t like yogurt) – you guessed it – more research is necessary.

Here's some more, perhaps simpler reading on this.

My Video on Molecular Biology

As I wrote earlier, I've run out of gas with respect to posting new insights on Alzheimer's research. But I'm still busy (and st...